Compliance
This section focuses on health care compliance and regulations – both national and state – including the ACA. It includes changes in health care law, regulation, and court decisions and their impact on health insurance professionals, employers, and individuals.
For Elizabeth Warren, it was supposed to be one more big idea in a campaign built around them: a promise that everyone could get government-funded health care, following the lead of her friend and fellow White House hopeful Bernie Sanders. Instead, "Medicare for All" is posing one of the biggest challenges to the Massachusetts senator's candidacy.
It’s not an across-the-board finding, but if you ask employees of small businesses how they feel about their benefits, you may be surprised to learn that 87 percent of them would accept additional benefits over a pay raise.
Curbing the cost of healthcare and increasing its affordability remain the top priorities for 93% of employers over the next three years, according to the 24th annual Best Practices in Health Care Employer Survey by Willis Towers Watson.
Employers are seeking more innovative ways to manage healthcare costs while hitting the pause button using high-deductible health plans (HDHPs) to do it, a new survey shows.
Technology continues to reshape the landscape of the benefits business. As employers increasingly rely on technology for everything from enrollment to administration and compliance, they look to their brokers for sound advice.
Employers may be getting better at communicating about benefits during open enrollment.
Prescription drug companies and trade groups shelled out millions of dollars to lobby Congress as it considered legislation aimed at reining in skyrocketing drug prices, according to new lobbying disclosure reports. The Pharmaceutical Research and Manufacturers of America (PhRMA) — the trade group representing branded drug companies — spent $6.2 million on lobbying in the third quarter of 2019, which ran from July through the end of September.
WASHINGTON — Democratic lawmakers in recent weeks have begun to advance an argument long seen as something of a third rail in U.S. politics: that slightly less biomedical innovation might be worth a dramatic reduction in drug prices. The surprising candor has come amid pushback to House Speaker Nancy Pelosi’s high-profile drug pricing bill, which the trade group PhRMA this month said represented “nuclear winter” for the development of new medicines.
Employers are increasingly seeking out benefits brokers who can assist them with compliance issues. That’s according to a new employer survey from Zywave, which found the vast majority of clients (98%) want their brokers to assist them with compliance related questions and 78% want compliance resources.
If you are among the Californians who buy your own health insurance, a surprise may await you as the enrollment period for 2020 coverage opens this week. Starting Jan. 1, California will become the first state to offer subsidies to middle-income people who make too much money to qualify for the federal tax credits that help consumers buy health coverage through Covered California, the state’s Affordable Care Act insurance exchange.